New heart device available for patients who have run out of options
NCT ID NCT07421557
First seen Feb 20, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This program provides expanded access to Occlutech's atrial flow regulator (AFR), a device designed to help manage certain heart conditions. It is available for patients who have no other treatment options and meet FDA criteria. The goal is to control the disease and improve heart function, but ongoing medical care is still needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new related studies are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Individual Sites Across the U.S.
AVAILABLEMaple Grove, Minnesota, 55369, United States